Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
 
Articles by Pietro Andreone
Total Records ( 2 ) for Pietro Andreone
  Helen Cooksley , Shilpa Chokshi , Yafit Maayan , Heiner Wedemeyer , Pietro Andreone , Richard Gilson , Thomas Warnes , Simona Paganin , Fabien Zoulim , David Frederick , Avidan U. Neumann , Carol L. Brosgart and Nikolai V. Naoumov
  Weak T-cell reactivity to hepatitis B virus (HBV) is thoughtto be the dominant cause for chronic HBV infection. Treatmentwith adefovir dipivoxil (ADV) increases the rate of HBV e antigen(HBeAg) loss; however, the immune mechanisms associated withthis treatment response are not understood. Serial analysisof HBV-specific CD4+ T-cell reactivity was performed during48 weeks of therapy with ADV and correlated with treatment outcomefor 19 HBeAg-positive patients receiving ADV (n = 13) or theplacebo (n = 6). We tested T-cell reactivity to HBV at sevenprotocol time points by proliferation, cytokine production,and enzyme-linked immunospot assays. A panel of serum cytokineswas quantitated by cytokine bead array. ADV-treated patientsshowed increased CD4+ T-cell responses to HBV and lower serumlevels of cytokines compared to those of placebo-treated patients.Enhanced CD4+ T-cell reactivity to HBV, which peaked at treatmentweek 16, was confined to a subgroup of ADV-treated patientswho achieved greater viral suppression (5.3 ± 0.3 log10copies/ml [mean ± standard error of the mean {SEM}] serumHBV DNA reduction from baseline) and HBeAg loss, but not toADV-treated patients with moderate (3.4 ± 0.2 log10 copies/ml[mean ± SEM]) viremia reduction who remained HBeAg positiveor to patients receiving the placebo. In conclusion, T-cellreactivity to HBV increases in a proportion of ADV-treated patientsand is associated with greater suppression of HBV replicationand HBeAg loss.
  Anthony Tanoto Tan , Elisabetta Loggi , Carolina Boni , Adeline Chia , Adam J. Gehring , Konduru S. R. Sastry , Vera Goh , Paola Fisicaro , Pietro Andreone , Christian Brander , Seng Gee Lim , Carlo Ferrari , Florian Bihl and Antonio Bertoletti
  Repertoire composition, quantity, and qualitative functional ability are the parameters that define virus-specific T-cell responses and are linked with their potential to control infection. We took advantage of the segregation of different hepatitis B virus (HBV) genotypes in geographically and genetically distinct host populations to directly analyze the impact that host and virus variables exert on these virus-specific T-cell parameters. T-cell responses against the entire HBV proteome were analyzed in a total of 109 HBV-infected subjects of distinct ethnicities (47 of Chinese origin and 62 of Caucasian origin). We demonstrate that HBV-specific T-cell quantity is determined by the virological and clinical profiles of the patients, which outweigh any influence of race or viral diversity. In contrast, HBV-specific T-cell repertoires are divergent in the two ethnic groups, with T-cell epitopes frequently found in Caucasian patients seldom detected in Chinese patients. In conclusion, we provide a direct biological evaluation of the impact that host and virus variables exert on virus-specific T-cell responses. The discordance between HBV-specific CD8 T-cell repertoires present in Caucasian and Chinese subjects shows the ability of HLA micropolymorphisms to diversify T-cell responses and has implications for the rational development of therapeutic and prophylactic vaccines for worldwide use.
 
 
 
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility